微生态制剂金双歧治疗喂养不耐受早产儿的观察

目的:探讨喂养不耐受早产儿的治疗方法,提高早产儿的存活率。方法:76例喂养不耐受早产儿随机分为治疗组40例,对照组36例,两组均按照常规护理和治疗,并予静脉营养,治疗组在喂奶后口服或鼻饲微生态制剂金双歧三联活菌片0.5g,2次/d,疗程5d。结果:治疗组显效32例,有效7例,无效1例,总有效率97.5%;对照组显效8例,有效18例,无效10例,总有效率72.2%;两组有效率比较X2=7.84,P<0.01,差异有显著性。结论:应用微生态制剂金双歧治疗喂养不耐受早产儿效果确切,未发现不良反应,且缩短早产儿的住院时间。

Clinical Observation of the Therapeutic Efficacy of "GOLDEN BIFID" on Premature with Feeding Intolerance

Objective: To observe the clinical efficacy of "Golden bifid" on the treatment of premature with feeding intolerance.Method: 76 cases of premature with feeding intolerance were assigned into two groups by randomization:the therapeutic group contained 40 cases and the control group contained 36.Both group of infants were given the routine nursery and treatment,intravenous transfusion was given as well.Moreover,the infants of the therapeutic group were extra given the "Golden bifid"(A pill of tri-covalent viable organism from Inner Mongolian Shuang Qi drug company) by oral or nasal feeding,0.5g a time,two times a day,and the period of treatment lasted for 5 days.Result: In the therapeutic group,32 cases showed excellence (obviously effective),7 cases showed utility(effective) and 1 case showed ineffective,the total effective rate is 97.5%.Among the control group,8cases showed excellence(obviously effective),18 cases showed utility(effective) and 10 cases showed ineffective,the total effective rate is 72.2%.After comparing the effective rate of both groups(by chi-square test),X~2=7.84,P<0.01,the difference is of significance.Conclusion: The clinical efficacy of "golden bifid" on the treatment of premature with feeding intolerance has been proved certainly,without side effects yet.